The Gemini Capsule
An investigational implant designed to maintain the space of the capsular bag after cataract removal and to provide a secure, stable position for an intraocular lens.
Innovation
Omega Ophthalmics and the Gemini Capsule
Dr. Wörtz is Chief Medical Officer of Omega Ophthalmics, the company developing the Gemini Capsule. The Gemini Capsule is an investigational device and is not approved for use or commercial distribution in the United States.
Prosthetic capsular devices
Named inventor on more than 40 granted U.S. patents for prosthetic capsular devices and related ophthalmic implants, assigned to Omega Ophthalmics.
Toward U.S. regulatory review
In August 2026 Omega announced a scheduled FDA pre-submission meeting as it advances the Gemini Refractive Capsule toward U.S. approval.